Hesperetin and Naringenin sensitize human epidermal growth factor receptor-2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors

B C Bhavya, Mathew Steephan, T R Santhosh Kumar, A. Sabu, M Haridas. Hesperetin and Naringenin sensitize human epidermal growth factor receptor-2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors. Life Sciences, 160 (2016) 47–56.